Non-survivors (n = 34) | Survivors (n = 90) | p Value | |
---|---|---|---|
Computer tomography classification—n (%) | 0.01 | ||
Type 1 | 0 | 0 | |
Type 2 | 5 (14.7) | 25 (27.8) | |
Type 3 | 6 (17.6) | 15 (16.7) | |
Type 4 | 9 (26.5) | 13 (14.4) | |
Type 5 | 6 (17.6) | 32 (35.6) | |
Type 6 | 8 (23.5) | 5 (5.6) | |
CT with high risk of death (types 3, 4, 6)—n (%) | 23 (67.6) | 33 (36.7) | 0.002 |
Gender female—n (%) | 13 (38.2) | 15 (16.7) | 0.02 |
Age (years)—median (p 25–75) | 65 (55–75) | 46 (28–62) | < 0.001 |
Temperature (°C)—median (p 25–75) | 36.0 (35.0–37.0) | 37.0 (36.0–37.3) | 0.07 |
Creatinine (mg/dl)—median (p 25–75) | 0.80 (0.70–1.10) | 0.80 (0.70–1.00) | 0.50 |
Glycemia (g/dL)—median (p 25–75) | 160 (125–191) | 139 (121–167) | 0.11 |
Sodium (mEq/L)—median (p 25–75) | 141 (136–147) | 140 (138–143) | 0.41 |
Bilirubin (mg/dl)—median (p 25–75) | 0.70 (0.53–1.05) | 0.60 (0.40–0.80) | 0.06 |
Lactic acid (mmol/L) median (p 25–75) | 2.30 (1.25–4.58) | 1.75 (1.10–2.50) | 0.08 |
PaO2 (mmHg)—median (p 25–75) | 142 (97–195) | 148 (110–242) | 0.45 |
PaO2/FI02 ratio—median (p 25–75) | 294 (167–395) | 336 (246–400) | 0.11 |
Leukocytes—median*103/mm3 (p 25–75) | 14.9 (9.7–21.6) | 13.9 (10.1–19.0) | 0.47 |
Fibrinogen (mg/dl)—median (p 25–75) | 348 (300–475) | 371 (286–471) | 0.70 |
aPTT (seconds)—median (p 25–75) | 29 (25–37) | 28 (25–31) | 0.25 |
INR—median (p 25–75) | 1.12 (1.03–1.48) | 1.11 (1.00–1.24) | 0.19 |
Platelets—median*103/mm3 (p 25–75) | 172 (125–232) | 182 (135–238) | 0.49 |
Hemoglobin (g/dL)—median (p 25–75) | 11.9 (10.0–13.7) | 11.2 (10.0–13.0) | 0.73 |
ISS—median (ppe 25–75) | 25 (25–25) | 25 (25–34) | 0.28 |
Glasgow Coma Scale score—median (p 25–75) | 4 (3–7) | 7 (5–8) | < 0.001 |
APACHE–II score—median (p 25–75) | 25 (23–28) | 18 (14–22) | < 0.001 |
ICP (mmHg)—median (p 25–75) | 25 (11–30) | 15 (14–20) | 0.36 |
CPP (mmHg)—median (p 25–75) | 61 (52–70) | 68 (57–70) | 0.60 |
Malondialdehyde (nmol/mL)—median (p 25–75) | 2.03 (1.36–4.12) | 1.35 (1.05–1.77) | < 0.001 |